Category Archives: Corporate

Latest From Corporate

My Keynote Address at the 2016 BIO International Convention

Greenwood_Jim_BTN

Yesterday, the voters of California had their say. The general election is upon us. It’s Clinton vs. Trump. Fasten your seat belts, folks. This election is going to be fascinating, but it’s not going to be pretty. Today, we turn to politics, and more specifically, the intersection between politics and policy. In a few minutes, we’ll hear from three Washington veterans. They’ll preview a race for the White House that figures to be unlike anything Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Welcomes Seven New Board Members

new-bio-logo

BIO elected seven new members to its Board of Directors, voted upon at this year’s Board Meetings, held this week in New York City. The following individuals were elected to the Health Section Governing Board: Christopher Boerner, President and Head of the U.S. Commercial Business, BMS Mark Alles, President and Chief Operating Officer, Celgene Gary Zieziula, President and Managing Director, EMD Serono Elizabeth Lewis, Chief Counsel and Chief Compliance Officer, Takeda Pharmaceuticals Jean-Christophe Tellier, Chief Read More >

Corporate  |  Leave a comment  |  Email This Post
Tags: , ,

The New Biotechnology Innovation Organization

new-bio-logo

At BIO, new discoveries in research and development are constantly being made by our members. We take pride in the contributions they have made across a diverse range of biotechnology industries, including: healthcare, agricultural, industrial and environmental. As one of the world’s strongest catalysts for innovation, our role within the biotechnology community requires us to reflect on who we are, what we do and how we can better serve our members in future. Biotechnology scientists Read More >

Jim's Corner  |  Leave a comment  |  Email This Post

Driving Innovation in Cancer: Startup Challenge

The Center for Advancing Innovation (CAI) announces the launch of the Nanotechnology Startup Challenge for Cancer (NSC2). NSC2 is an open innovation competition designed to bring promising cancer nanotechnology inventions to market.

Corporate  |  Leave a comment  |  Email This Post

Wall Street Journal: Patients Deserve Better

Greenwood_Jim_BTN

In case you missed it, The Wall Street Journal published my Letter to the Editor this morning.  I make the point that the problem isn’t innovative new treatments from America’s biopharma industry but rather the complex web of health-insurance schemes patients must navigate to access needed medicines. Here is the text of the letter: “Innovative treatments and cures have radically transformed how we treat disease—saving and improving lives and providing tremendous benefits to patients and Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,